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Background. Our aim was to quantify human involuntary isometric skeletal muscle strength
during anaesthesia with propofol, sevo¯urane, or spinal anaesthesia using bupivacaine.
Methods. Thirty-three healthy patients undergoing anaesthesia for elective lower limb surgery
were investigated. Twenty-two patients received a general anaesthetic with either propofol
(n=12) or sevo¯urane (n=10); for the remaining 11 patients spinal anaesthesia with bupivacaine
was used. We used a non-invasive muscle force assessment system before and during anaesthe-
sia to determine the contractile properties of the ankle dorsi¯exor muscles after peroneal
nerve stimulation (single, double, triple, and quadruple stimulation). We measured peak
torques; contraction times; peak rates of torque development and decay; times to peak torque
development and decay; half-relaxation times; torque latencies.
Results. Males elicited greater peak torques than females, medians 6.3 vs 4.4 Nm, respectively
(P=0.0002, Mann-Whitney rank-sum test). During sevo¯urane and propofol anaesthesia, muscle
strength did not differ from pre-anaesthetic values. During spinal anaesthesia, torques were
diminished for single-pulse stimulation from 3.5 to 2.0 Nm (P=0.002, Wilcoxon signed rank
test), and for double-pulse from 7.6 to 5.6 Nm (P=0.02). Peak rates of torque development
decreased for single-pulse stimulation from 113 to 53 Nm s±1 and for double pulse from 195 to
105 Nm s±1. Torque latencies were increased during spinal anaesthesia.
Conclusions. At clinically relevant concentrations, propofol and sevo¯urane did not in¯uence
involuntary isometric skeletal muscle strength in adults, whereas spinal anaesthesia reduced
strength by about 20%. Muscle strength assessment using a device such as described here
provided reliable results and should be considered for use in other scienti®c investigations to
identify potential effects of anaesthetic agents.
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Anaesthetics in¯uence voltage-gated ion channels in the
nervous system as well as in skeletal and cardiac muscle. By
enhancing sodium current decay in the muscle cell they
change signal transduction and may have neuromuscular
blocking agent properties; propofol, local anaesthetics, and
inhaled anaesthetics have this ability.1 2 Moreover, anaes-
thetic agents may alter contractile function by inhibition of
cholinergic neurotransmission.3 Such altered activities
could in¯uence recovery from anaesthesia.
To determine muscle strength, isometric assessment tools
have to be distinguished from dynamic tools. The measured
values are strongly in¯uenced by an investigator's experi-
ence and the patient's voluntary efforts, so results are not
always objective and reproducible.4 To improve objectivity,
®xed devices have been developed. By using electrical
nerve stimulation and electronic data acquisition, it is now
possible to get quantitative, non-invasive muscle force
assessment results, independent of a subject's voluntary
efforts.5±8
We used a muscle force assessment system, which was
originally developed for neurological trials, to investigate
the in¯uence of propofol, sevo¯urane, or spinal anaesthesia
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with bupivacaine on human involuntary isometric skeletal
muscle strength following electrical stimulation.
Methods
Before and during anaesthesia, the involuntary isometric
skeletal muscle strength of the ankle dorsi¯exor muscles
after peroneal nerve stimulation in humans was investi-
gated.
Patients
All 33 patients gave their written informed consent, and the
Human Ethics Committee of the University of Basel,
Switzerland approved the experimental protocol. All
patients were ASA I and were to undergo orthopaedic or
venous surgery to the lower limb. The patients chose
whether to receive either spinal anaesthesia or general
anaesthesia. Those patients who chose to receive general
anaesthesia were allocated randomly to receive either
propofol or sevo¯urane for induction and maintenance of
anaesthesia.
Muscle force assessment system
For nerve stimulation, a Grass S11 stimulator (Grass
Medical Instruments, Quincy, MA) was used. A special
device that securely held the subject's leg was used for
quanti®cation of muscle torque (Fig. 1).5±8 The torque was
measured by a strain gauge (SG-2/350-LY41 Strain Gauges,
OMEGA Engineering, Inc., Stamford, CT) attached to an
aluminium bar that restrained movement of the footplate.
The output of the strain gauge was ampli®ed (ampli®er:
Grass Medical Instruments); voltage changes proportional
to the muscle torque were digitized through a data
acquisition card (DAQCardÔ-1200, National Instruments,
Austin, TX), converted into force and then stored on a
personal computer. All data acquisition and analysis
programs were written with LabVIEW 2 (National
Instruments, Austin, TX).
Experimental protocol
All patients received midazolam 0.1 mg kg±1 orally 1 h
before the experiments. A sample of blood was analysed for
Na+, K+, Ca2+, phosphate, urea, creatine kinase, glucose,
and haemoglobin concentrations, and a coagulation screen
was done. The circumference and skin fold thickness of the
lower leg were measured.
After arrival in the operating theatre, an i.v. catheter was
sited and an infusion of Ringer lactate solution (500 ml) was
started. Standard monitoring was attached and a surface
temperature probe was used to determine the temperature
over the tibialis anterior muscle (GeniusÔ, infrared therm-
ometer, Sherwood-Davis & Geck, Gosport, UK): for
patients receiving general anaesthesia, the Bispectral
IndexÔ was monitored also.
The muscle force assessment system was attached to each
patient as follows: the patient was laid on the surgical table
with one leg strapped in a stabilizing device that was ®tted
with a force measuring boot into which the foot was placed.
A convective warm-air system was used to minimize
variability in dorsi¯exor muscle temperature; the skin
temperature of the leg was maintained between 31 and
32°C. After cleaning the skin with an alcoholic wipe, a pair
of small ball-shaped electrodes was pressed tightly against
the skin behind the head of the ®bula for transcutaneous
common peroneal nerve stimulation. An electromyogram
(EMG) of the tibialis anterior muscle was recorded with
surface patch electrodes.10
The supramaximal voltage (approximately 50±90 V with
0.3 ms duration) was used for stimulation and this was
determined by increasing the voltage until no further
increases in muscle twitch torque and in the EMG signal
of the ankle dorsi¯exors were detected. The optimal muscle
length for isometric contraction (in this case, the ankle joint
position) was determined by moving the torque plate until
twitch torques reached a maximum.9 This position of the
torque plate was then ®xed and kept unchanged during the
experiment. Baseline measurements were then performed.
The protocol included single, double, triple, and quadruple-
pulse peroneal nerve stimulation.5±8 These were unidirec-
tional depolarizing pulse stimuli with a pulse duration of
0.3 ms. The pulse interval for the multiple pulse stimula-
Fig 1 Muscle-force assessment system to determine involuntary isometric
torque in humans.5±8 It is composed of four main components: (i) a
stabilizing device consisting of two metal bars, straps and a boot. The
boot is ®xed on a foot plate that can be rotated and ®xed at any position
between ±40 and 40°. (ii) A strain gauge system with a Wheatstone
bridge circuit that detects the evoked torque produced by the stimulated
ankle dorsi¯exor muscles. (iii) A stimulator/ampli®er unit that can supply
variable stimulus pulse amplitudes and pulse durations and can amplify
the voltage changes, evoked by the torque of the stimulated muscle. (iv)
A computer with data acquisition software for recording, analysing and
displaying all signals simultaneously.
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tions was 5 ms. Between each set of stimuli there was a
2 min rest period. After baseline measurements were
®nished, general or spinal anaesthesia was administered.
One of two general anaesthetic regimens was used: (i) a
target controlled infusion (TCI) of propofol with the target
concentration set at 5 mg ml±1; (ii) inhalation induction with
sevo¯urane 6±8 vol%, in oxygen 100%, followed by
maintenance with sevo¯urane at an end-tidal concentration
of 3±3.5 vol%. A laryngeal mask was used in both groups
for airway maintenance and ventilation of the lungs was
controlled to keep the EE¢CO2 at 4.5±5 kPa. After a 20 min
stabilization period, the measurements were repeated.
During this measurement period, the Bispectral IndexÔ
was between 40 and 50. In the propofol group, blood was
taken and the plasma obtained was used to determine the
concentration of propofol by high performance liquid
chromatography with ¯uorescence detection.
Spinal anaesthesia was performed with hyperbaric
bupivacaine 0.5%, 0.2 mg kg±1. When a stable sensory
level was reached (upper level between the 6th and 9th
thoracic dermatome), the second set of measurements was
performed. Completion of both sets of measurements took
about 1 h for each subject.
Data analysis
The following indices of isometric skeletal muscle per-
formance were determined: (i) peak torque (Nm): the
maximum amount of developed involuntary isometric
muscle torque; (ii) contraction time (ms): time from the
onset of torque development to peak torque; (iii) half-
relaxation time (ms): time for the torque to decay from its
peak to 50% of peak torque; (iv) peak rate of torque
development (Nm s±1): the maximum rate (®rst derivative)
of torque development; (v) peak rate of torque decay
(Nm s±1): the maximum rate of torque decay; (vi) time to
peak torque development (ms): the time from the onset of
torque development to the peak rate of torque development;
(vii) time to peak torque decay (ms): the time from the peak
rate of torque development to the peak rate of torque decay;
(viii) torque latency (ms): the time from the stimulus to the
onset of torque development (Fig. 2).
Statistical analysis
The StatView program (ADEPTâ, Hertfordshire, UK) was
used. Pre-anaesthetic and anaesthetic muscle force meas-
urements for each group were compared with the Wilcoxon
signed rank test. The values between the different anaes-
thetic groups were analysed with the Kruskal±Wallis test.
Measurements in men and women were compared with the
Mann±Whitney rank-sum test. P-values <0.05 were con-
sidered to be signi®cant.
Results
Thirty-three patients were recruited and their characteristics
are shown in Table 1. A total of 376 measurements were
performed. The same physician performed the measure-
ments for all patients.
The within-session test±retest reliability for peak torque
was 6%. The peak torque development (for all stimulus
protocols combined) of male patients from all groups
combined was greater than that of female patients, medians
6.3 (range 1.2±24.9) vs 4.4 (0.8±12.0) Nm, respectively
(P=0.0002, Mann-Whitney rank-sum test). Male patients
also had a greater peak torque development during anaes-
thesia, 8.9 (range 0.5±25.9) vs 5.0 (0.5±18.0) Nm
(P<0.0001).
During spinal anaesthesia, peak torque values were
diminished for single- and double-pulse stimulation but
not for the other stimulation modalities (Table 2). The peak
rates of torque development decreased for single- and
double-pulse stimulation and the torque latency period for
single-pulse stimulation only was increased (Table 2).
During spinal anaesthesia with bupivacaine, the peak
torque values for single- and double-pulse stimulation were
decreased compared with the corresponding values from the
groups treated with propofol or sevo¯urane (see Table 2). In
the propofol and sevo¯urane groups, pre-anaesthetic and
anaesthetic values were not signi®cantly different
(Wilcoxon signed rank test, Table 2).
Discussion
We have demonstrated that clinical concentrations of
propofol or sevo¯urane did not in¯uence isometric skeletal
muscle strength in healthy adults, but spinal anaesthesia did
have a small effect.
Propofol blocks voltage-gated channels and thus has a
neuromuscular blocking agent effect. This occurs especially
in pathological conditions that result in a higher fraction of
inactivated channels, such as hypoxia, myotonia, or
Fig 2 Record of the twitch torque and differentiated torque of the ankle
dorsi¯exor muscles. Compound muscle action potential is schematic, the
stimulus is indicated by the dashed arrow. (i) Peak torque (PT); (ii)
contraction time; (iii) half-relaxation time; (iv) peak rate of torque
development; (v) peak rate of torque decay; (vi) time to PT development;
(vii) time to PT decay; (viii) torque latency; Nm: newtonmeter; s:
seconds.
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ischaemia.11 12 Thus, propofol might be the drug of choice
for induction of anaesthesia in patients with myotonia.
Propofol also exerts a direct negative inotropic effect on
failing and non-failing human myocardium, although only
at concentrations exceeding the clinical-dose range.13
Volatile anaesthetics inhibit skeletal muscle sodium
channels. Mountsey and colleagues describe a dose-depend-
ent enhancement of the rate of sodium current decay and a
small reduction in sodium current amplitude in rat skeletal
muscle for halothane.1 In animals, the compound muscle
action potentials are signi®cantly lower during application
of volatile anaesthetics.14 15 Bouhemad and colleagues
describe a moderate negative inotropic effect in rat
diaphragm muscle in vitro during application of iso¯urane
(at 23 MAC).16 In an in vitro study using animal tissue,
sevo¯urane did not enhance the reduction of tension
induced by diaphragmatic fatigue but enhanced the pro-
longation of contraction time and half-relaxation time.17
Halothane causes a decreased calcium sensitivity and
decreased isometric tension in human type I, but not type
II skeletal muscle ®bres.18 On the other hand, there is an
increased maximal skeletal muscle Ca2+-activated force in
the presence of volatile anaesthetics.19 Moreover, volatile
anaesthetics have a direct action on neuromuscular trans-
mission.3 20 Thus, the effects on striated muscles remain
controversial.
We found no in¯uences of sevo¯urane or propofol on
human isometric skeletal muscle strength in vivo. The short-
Table 2 Parameters of involuntary isometric strength measurements of the ankle dorsi¯exors in humans. Peak torque (PT): the maximum amount of
developed involuntary isometric muscle torque; contraction time: time from onset of torque to time of PT; peak rate of torque development: the maximum
rate of torque development; peak rate of torque decay: the maximum rate of torque decay; half-relaxation time: time from PT to time when torque decays to
half of PT; torque latency: the time from stimulus to the onset of torque development. 1=single pulse; 2=double pulse; 3=triple pulse; 4=quadruple pulse. Data
are median (range). *P=0.002; **P=0.02; ***P=0.01; ²P=0.005 with bupivacaine anaesthesia vs pre-anaesthesia, Wilcoxon signed rank test. ²²P=0.004;
²²²P=0.02 with bupivacaine anaesthesia vs propofol and sevo¯urane anaesthesia, Kruskal±Wallis test
Characteristics Propofol 1% Sevo¯urane Bupivacaine 0.5%
(n=12) (n=10) (n=11)
Pre-anaesthesia With anaesthesia Pre-anaesthesia With anaesthesia Pre-anaesthesia With anaesthesia
PT 1 (Nm) 4.4 (0.9 to 9.2) 4.7 (0.5 to 8.6) 5.7 (1.5 to 9.4) 5.1 (1.4 to 9.9) 3.5 (0.8 to 9.4) 2.0 (0.5 to 10.1)* ²²
PT 2 (Nm) 8.5 (4.4 to 13.0) 10.2 (0.8 to 15.3) 10.4 (2.8 to 14.4) 9.3 (2.9 to 13.6) 7.6 (1.8 to 17.6) 5.6 (1.6 to 19.4)** ²²²
PT 3 (Nm) 14.3 (6.5 to 17.9) 15.8 (1.1 to 19.0) 9.9 (2.6 to 17.6) 8.7 (4.3 to 16.0) 9.9 (0.8 to 22.4) 8.5 (0.8 to 22.9)
PT 4 (Nm) 17.7 (16.3 to 20.9) 20.0 (17 to 21.5) 9.8 (3.6 to 18.5) 10.1 (5.5 to 17.3) 11.6 (2.6 to 24.9) 10.1 (3.6 to 25.1)
Contraction time
1 (ms)
94 (37 to 134) 97 (68 to 227) 93 (67 to 184) 86 (34 to 191) 84 (41 to 156) 82 (36 to 190)
Peak rate of
torque 1
development
(Nm s±1)
113 (15 to 188) 86 (15 to 203) 120 (38 to 158) 116 (30 to 173) 113 (15 to 203) 53 (15 to 225)*** ²²²
Peak rate of
torque 2
development
(Nm s±1)
199 (30 to 465) 188 (23 to 945) 251 (60 to 307) 199 (90 to 322) 195 (38 to 382) 105 (38 to 382)**
Peak rate of
torque 1 decay
(Nm s±1)
±49 (±68 to ±8) ±41 (±75 to ±15) ±45 (±300 to ±15) ±45 (±90 to ±23) ±30 (±97 to ±15) ±23 (±83 to ±8)
Half-relaxation
time 1 (ms)
115 (70 to 170) 105 (45 to 205) 115 (55 to 145) 105 (60 to 135) 125 (80 to 185) 120 (75 to 185)
Torque latency
1 (ms)
23 (±3 to 27) 25 (±92 to 36) 22 (18 to 26) 23 (20 to 33) 21 (19 to 24) 23 (18 to 31)²
Table 1 Patient characteristics and anaesthetic data. Data are mean (SD) or number. *P=0.02 sevo¯urane vs bupivacaine
Characteristics Propofol 1% Sevo¯urane Bupivacaine 0.5%
(n=12) (n=10) (n=11)
Age (yr) (range) 38.3 (17±61) 28.3 (16±60)* 42.4 (28±68)
Gender (male/female) 5/7 6/4 7/4
Weight (kg) 70.8 (14.3) 66.8 (13.3) 77.3 (15.6)
Height (cm) 170 (8) 174 (10) 171 (8)
Lower leg circumference (cm) 36 (2) 34 (3) 35 (6)
Lower leg skin fold (mm) 8 (7) 9 (7) 12 (11)
Plasma propofol concentration (mg ml±1) 3.9 (0.7) ± ±
Dose of bupivacaine (mg) ± ± 15 (3)
End-tidal sevo¯urane concentration (vol%) ± 3.6 (0.6) ±
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term effect-site equilibration time of propofol and its high
drug transfer rate to the peripheral compartment enable us to
assume that propofol concentrations in skeletal muscle and
plasma were similar. The plasma concentration of propofol
was in the range of the half-maximum blocking concentra-
tion of skeletal muscle sodium channels; thus, the effects
were too small to be measured in our clinical setting.11 21
Since volatile agents reduce isometric force values by
about 10% of baseline values in vitro,16 their effects again
could have been too small to be measured in vivo. Moreover
effects of volatile agents are supposed to be more
pronounced during muscle fatigue.17 The distribution of
muscle ®bre types with their different susceptibility towards
volatile anaesthetics can also vary between subjects.22
Spinal anaesthesia blocks the roots of the nerve ®bres and
the super®cial layers of the spinal cord.23 This results in a
¯accid paralysis of the muscles and block of the sympathetic
out¯ow. Whereas the main part of this central sympathetic
out¯ow innervates organs such as the heart, lungs, sweat
glands, and skin, only a minor component reaches the
skeletal muscle and has no measurable in¯uence on muscle
tone, as was demonstrated by Smith during spinal anaes-
thesia.24 Moreover, during static exercise in humans, central
command was found to contribute very little to the
activation of sympathetic out¯ow in skeletal muscle.25
However, peripheral afferent impulses from muscle me-
chanoreceptors (muscle spindles), Golgi tendon organs, and
chemosensitive endings in muscles in¯uence sympathetic
nerve activity and skeletal muscle tension by re¯ex
mechanisms. During static handgrip, an increased sympa-
thetic discharge to muscle was measured, and muscle
sympathetic nerve activity returned to control values during
relaxation.26 27 Electrically evoked involuntary biceps
¯exion also results in increased muscle sympathetic nerve
activity.26 During spinal anaesthesia, these afferent im-
pulses are blocked, which could explain the lower values for
evoked torque and peak rate development. Direct actions of
local anaesthetics on the pre-synaptic, post-junctional, and
muscle membranes are only relevant for i.v. application
with a moderate to high drug-plasma level and not for spinal
application, thus excluding this effect from contributing to
our ®ndings.28
The following points must be considered when assessing
the relevance of our results. First, for a complete assessment
of muscle function it is desirable to study strength variables
on the load continuum from isotonic (with low loads) to
isometric (with high loads) conditions. In our setting, only
isometric measurements were performed. However, nega-
tive inotropic effects of anaesthetics typically are found
under isometric and not isotonic conditions.16 Secondly,
completely standardized conditions are only possible in
in vitro studies; for example, inter-subject variability in
perfusion, tissue temperature, and muscle cross-sectional
area may have in¯uenced the test results. However, clinical
trials are required to con®rm in vitro results under clinical
conditions and such variability can be minimized using
appropriate study groups.
Our study is the ®rst to use the described muscle-force
assessment system during anaesthesia. This new system
made it possible to obtain objective and reliable results,
independent of a subject's voluntary effort.5±8 The system is
versatile, enabling the examination of different muscle
groups.7 Thus, we recommend such a system to investigate
skeletal muscle strength, for example, in patients with
potential muscle atrophy, critical illness polyneuropathy, or
myopathy.
In conclusion, we evaluated the isometric skeletal muscle
strength of the lower leg under different anaesthetic
regimens in humans. At clinically relevant concentrations,
neither sevo¯urane nor propofol changed muscle strength,
whereas during spinal anaesthesia there was a small
impairment of strength. The skeletal neuromuscular block-
ing agent properties of anaesthetics do not seem to have a
profound effect on isometric skeletal muscle strength in
humans in vivo.
Acknowledgement
The authors thank Mrs Joan Etlinger for excellent secretarial assistance.
References
1 Mounsey JP, Patel MK, Mistry D, John JE, Moorman JR. Protein
kinase C co-expression and the effects of halothane on rat
skeletal muscle sodium channels. Br J Pharmacolol 1999; 128:
989±98
2 Haeseler G, Piepenbrink A, Bu¯er J, et al. Structural
requirements for voltage-dependent block of muscle sodium
channels by phenol derivates. Br J Pharmacolol 2001; 132: 1916±
24
3 Wiklund CU, Lim S, Lindsten U, Lindahl SG. Relaxation by
sevo¯urane, des¯urane and halothane in the isolated guinea-pig
trachea via inhibition of cholinergic neurotransmission. Br J
Anaesth 1999; 83: 422±9
4 Knepler C, Bohannon RW. Subjectivity of forces associated with
manual-muscle test grades of 3+, 4±, and 4. Percept Mot Skills
1998; 87: 1123±8
5 Quinlan JG, Iaizzo PA, Lambert EH, Gronert GA. Ankle
dorsi¯exor twitch properties in malignant hyperthermia.
Muscle Nerve 1989; 12: 119±25
6 Brass TJ, Loushin MKH, Day JW, Iaizzo PA. An improved method
for muscle force assessment in neuromuscular disease. J Med Eng
Technol 1996; 20: 67±74
7 Hong JB, Iaizzo PA. Force assessment of the stimulated arm
¯exors: quanti®cation of contractile properties. J Med Eng
Technol 2002; 26: 28±35
8 Day JW, Sakamoto C, Parry GJ, Lehmann-Horn F, Iaizzo PA.
Force assessment in periodic paralysis after electrical muscle
stimulation. Mayo Clin Proc 2002; 77: 232±40
9 Marsh E, Sale D, McComas AJ, Quinlan J. In¯uence of joint
position on ankle dorsi¯exion in humans. J Appl Physiol 1981; 51:
160±7
10 Aminoff MJ. Nerves in the lower limb. In: Aminoff MJ, ed.
Electromyography in Clinical Practice, 2nd Edn. New York:
Churchill Livingstone Inc., 1987; 208
Skeletal muscle strength during anaesthesia
371
11 Haesler G, Stormer M, Bu¯er J, et al. Propofol blocks human
skeletal muscle sodium channels in a voltage-dependent manner.
Anesth Analg 2001; 92: 1192±8
12 Lehmann-Horn F, Jurkat-Rott K, Rudel R. Periodic paralysis:
understanding channelopathies. Curr Neurol Neurosci Rep 2002; 2:
61±9
13 Sprung J, Ogletree-Hughes ML, McConnell BK, et al. The effects
of propofol on the contractility of failing and nonfailing human
heart muscles. Anesth Analg 2001; 93: 550±9
14 Yamada H, Transfeldt EE, Tamaki T, et al. General anesthetic
effects on compound muscle action potentials elicited by single
or dual spinal cord stimulation. J Spinal Disord 1995; 8: 157±62
15 Yamada H, Transfeldt EE, Tamaki T, Torres F, Iaizzo PA. The
effects of volatile anesthetics on the relative amplitudes and
latencies of spinal and muscle potentials evoked by transcranial
magnetic stimulation. Spine 1994; 19: 1512±17
16 Bouhemad B, Langeron O, Orliaguet G, Coriat P, Riou B. Effects
of halothane and iso¯urane on the contraction, relaxation and
energetics of rat diaphragmatic muscle. Br J Anaesth 2002; 89:
479±85
17 Kagawa T, Nobuhiro M, Katsuya M, Kahoru N, Yaku H, Hidefumi
O. The effect of halothane and sevo¯urane on fatigue-induced
changes in hamster diaphragmatic contractility. Anesth Analg
1998; 86: 392±7
18 Tavernier B, Haddad E, Adnet PJ, Etchrivi TS, Lacroix D, Reyford
H. Isoform-dependent effects of halothane in human skinned
striated ®bers. Anesthesiology 1996; 84: 1138±47
19 Kunst G, Graf B, Schreiner R, Martin E, Fink R. Differential
effects of sevo¯urane, iso¯urane, and halothane on Ca(2+)
release from the sarcoplasmic reticulum of skeletal muscle.
Anesthesiology 1999; 91: 179±86
20 Stoelting RK. Inhaled anesthetics. In: Stoelting RK, ed.
Pharmacology and Physiology in Anesthetic Practice, 3rd Edn.
Philadelphia: Lippincott-Raven, 1999; 64
21 Fruen BR, Mickelson JR, Roghair TJ, Litterer LA, Louis CF.
Effects of propofol on Ca2+ regulation by malignant
hyperthermia-susceptible muscle membranes. Anesthesiology
1995; 82: 1274±82
22 Jaworowski A, Porter MM, Holmback AM, Downham D, Lexell J.
Enzyme activities in the tibialis anterior muscle of young
moderately active men and women: relationship with body
composition, muscle cross-sectional area and ®bre type
composition. Acta Physiol Scand 2002; 176: 215±25
23 Stoelting RK. Local anesthetics. In: Stoelting RK, ed. Pharmacology
and Physiology in Anesthetic Practice, 3rd Edn. Philadelphia:
Lippincott-Raven, 1999; 176
24 Smith DC. Central enhancement of evoked electromyographic
monitoring of neuromuscular function. Br J Anaesth 1991; 66:
562±5
25 Vissing SF, Scherrer U, Victor RG. Stimulation of skin
sympathetic nerve discharge by central command. Circ Res
1991; 69: 228±38
26 Mark AL, Victor RG, Nerhed C, Wallin BG. Microneurographic
studies of the mechanisms of sympathetic nerve responses to
static exercise in humans. Circ Res 1985; 57: 461±9
27 Wallin BG, Victor RG, Mark AL. Sympathetic out¯ow to resting
muscles during static handgrip and postcontraction muscle
ischemia. Am J Physiol 1989; 256: H105±10
28 Miller RD. Pharmacology of muscle relaxants and their
antagonists. In: Miller RD, ed. Anesthesia, 5th Edn. New York:
Churchill Livingstone, 2000; 464
Ginz et al.
372
